Thin
CAS: 2259884-03-0
High-Quality Mazdutide CAS NO: 2259884-03-0 Quotes, Service
Directly manufactured at our multi-ton chemical synthesis base. Provided with complete analytical data packages (RP-HPLC, MS, Residual Solvents) for Singaporean clinical studies, CDMO development, and institutional research.
The Republic of Singapore has solidified its position as the premier biomedical nexus of Southeast Asia. Driven by world-class infrastructure within Biopolis at One-North and large-scale industrial commercialization in the Tuas Biomedical Park, Singapore hosts over 30 leading multinational pharmaceutical entities alongside a thriving ecosystem of agile biotech startups, clinical research organizations (CROs), and translational academic hubs like A*STAR, NUS, and SingHealth Duke-NUS.
As the biomedical industry shifts its focus toward therapeutic peptides—particularly regarding cardiometabolic multi-agonists, localized gastrointestinal regeneration, and cell-penetrating immunomodulators—the local demand for dependable, high-purity Peptide Active Pharmaceutical Ingredients (APIs) has expanded dramatically. Singaporean pharmaceutical developers require reliable continuity of batch synthesis, microgram-to-kilogram scalability, and stringent analytical dossiers capable of meeting the scrutiny of both domestic and global health authorities.
Thinheal bridges this specialized supply demand by providing Singaporean enterprises with an integrated direct-from-manufacturer peptide platform. We combine China’s synthesis volume efficiencies with the stringent analytical expectations of international life-science procurement.
Procuring APIs in Singapore involves addressing distinct regional variables across the translational pipeline:
Deploying therapeutic peptides into Singaporean therapeutic product pipelines requires rigorous adherence to the regulatory framework governed by the Health Sciences Authority (HSA) under the Health Products Act.
Every peptide API batch shipped to Singapore includes lot-specific Certificate of Analysis (CoA), RP-HPLC chromatograms, and high-resolution ESI-MS or MALDI-TOF spectra.
Our analytical methods conform to harmonized international standards, guaranteeing seamless data transfer to downstream formulation plants.
Peptide APIs are temperature-sensitive molecules. We utilize calibrated VIP thermal insulated shippers with real-time temperature loggers.
The global pharmaceutical supply chain requires deep backward integration, cost predictability, and agile capacity. Located in Hangzhou's Heda Medicine Valley, Thinheal operates dedicated synthesis reactors, multi-stage preparative HPLC purification columns, and industrial-scale lyophilization skids capable of chemical synthesis at multi-ton annual capacities.
By producing our own standard and non-canonical protected amino acids, coupling reagents, and specialized resins (such as 2-Chlorotrityl chloride and Rink Amide AM resins), we insulate our Singaporean partners from upstream supply volatility and inflated third-party distribution markups.
Whether Singaporean procurement teams require exploratory peptides for NUS university research, early toxicology batches for SingHealth preclinical programs, or multi-kilogram commercial batches for export finished-dose manufacturers, our facility offers uninterrupted scalability.
Transparency is foundational to our enterprise partnerships. Below is our baseline pricing, minimum order quantities (MOQ), and release specifications tailored for procurement teams in Singapore.
| Peptide API Name | CAS Identifier | Primary Therapeutic Category | Standard Purity (HPLC) | Reference MOQ | Singapore Price Range (USD) | Lead Time (SIN Air) |
|---|---|---|---|---|---|---|
| Mazdutide | 2259884-03-0 | Dual GLP-1/GCGR Metabolic Agonist | ≥ 98.0% | 10 g | Custom Enterprise Quotation | 3–5 Business Days |
| Semax | 80714-61-0 | Nootropic & Neuroprotective Peptide | ≥ 99.0% | 50 g | $18.00 – $32.00 / g | Immediate Stock (48h) |
| MOTS-c | 1627580-64-6 | Mitochondrial Derived Peptide | ≥ 98.5% | 25 g | $24.00 – $45.00 / g | 3–5 Business Days |
| Cargrilintide | 1415456-99-3 | Long-Acting Amylin Analogue | ≥ 98.0% | 10 g | Inquire for Batch Tiers | 5–7 Business Days |
| Teduglutide | 287714-30-1 | GLP-2 Analogue / Intestinal Health | ≥ 99.0% | 5 g | Tiered Volume Pricing | 3–5 Business Days |
| Vasopressin | 50-57-7 | Vasoconstrictor / Antidiuretic Agent | ≥ 98.5% | 20 g | $22.00 – $38.00 / g | Immediate Stock (48h) |
| Orforglipron | 2212020-52-3 | Non-Peptide Oral GLP-1 Receptor Agonist | ≥ 99.0% | 25 g | Custom Scale Pricing | 3–5 Business Days |
| Thymosin β4 (TB500) | 77591-33-4 | Tissue Repair & Angiogenic Factor | ≥ 99.0% | 100 g | $12.00 – $22.00 / g | Immediate Stock (48h) |
| BPC-157 | 137525-51-0 | Gastric Cytoprotective Pentadecapeptide | ≥ 99.0% | 100 g | $14.00 – $25.00 / g | Immediate Stock (48h) |
| Bremelanotide (PT141) | 189691-06-3 | Melanocortin Receptor Agonist | ≥ 98.5% | 50 g | $19.00 – $34.00 / g | 3–5 Business Days |
| Thymosin Alpha 1 | 62304-98-7 | Thymic Immune System Modulator | ≥ 99.0% | 50 g | $35.00 – $65.00 / g | Immediate Stock (48h) |
| Thymalin | 63958-90-7 | Immuno-Stimulatory Polypeptide | ≥ 98.0% | 50 g | $16.00 – $29.00 / g | 3–5 Business Days |
* Note: Prices are indicative FOB/CIP Singapore terms based on volume scales (10g to 10kg+). Final formal quotes include lot testing and Certificate of Analysis documentation.
Our peptide APIs serve distinct segments of Singapore's multi-layered biotechnology, healthcare, and research infrastructure.
With Singapore's national "War on Diabetes" and high clinical interest in cardiometabolic therapeutics, our incretin dual and triple agonists (such as Mazdutide, Cargrilintide, and Orforglipron) supply leading academic laboratories investigating insulin sensitivity, lipid clearance, and satiety neurobiology.
Teduglutide and specialized tissue-regenerative peptides like BPC-157 are central to translational models studying Short Bowel Syndrome (SBS), intestinal barrier permeability, and microvascular restitution within gastrointestinal departments across local tertiary hospital networks.
Thymosin Alpha 1, Thymalin, and Semax represent essential drug substances for researchers evaluating cytotoxic T-lymphocyte maturation, immune resilience, neurodegenerative protection, and adjuvant clinical paradigms across Southeast Asian clinical trials.
The peptide therapeutics sector has entered an era of rapid technological transformation. The paradigm has shifted from native, rapidly degraded biological peptides toward heavily engineered molecules possessing elongated half-lives, multi-receptor target affinities, and alternate non-invasive delivery options.
1. Multi-Targeted Incretin Co-Agonists: Beyond single GLP-1 receptor targeting, next-generation drugs incorporate dual GCGR, GIP, and amylin receptor activity (such as Mazdutide and Cargrilintide) to maximize metabolic regulation while preserving lean mass.
2. Synthetic Non-Peptide Agonists: Small-molecule oral alternatives like Orforglipron illustrate the blurring lines between canonical peptide solid-phase chemistry and complex heterocyclic organic synthesis, enabling once-daily oral dosing regimens.
3. Advanced Peptide-Drug Conjugates (PDCs): Peptides are increasingly deployed as homing vectors for targeted cytotoxic or radiopharmaceutical payloads, offering higher tumor-tissue penetration and lower off-target toxicity than heavy monoclonal antibodies.
To keep pace with these industry developments, procurement teams must look beyond unit price and secure partnerships founded on:
The following 8 active substances represent proven commercial synthesis targets manufactured under rigorous process controls and available for rapid shipment to Singapore.
Key information regarding regulatory paperwork, import permits, analytical verification, and delivery timelines for Singaporean pharmaceutical buyers.
Each shipment is dispatched with commercial invoices, airway bills, packing lists, detailed material safety data sheets (MSDS/SDS), and a batch-specific Certificate of Analysis (CoA) referencing HPLC purity, identity by MS, residual solvents, water content, and endotoxin levels. Where required for investigational use, we provide scientific rationale declarations.
We partner with validated cold-chain forwarders specializing in life sciences (including World Courier, DHL Medical Express, and FedEx Priority Cold). Materials are packed in temperature-controlled vacuum-insulated shippers (2–8°C or dry ice -20°C / -80°C) equipped with single-use USB temperature data loggers that buyers download upon arrival at Changi (SIN).
Yes. Standard SPPS yields peptides in trifluoroacetate (TFA) salt forms, which may interfere with sensitive cellular assays or clinical evaluations. We operate automated preparative ion-exchange chromatography systems capable of converting peptide APIs to acetate, hydrochloride, or sodium salt forms with residual TFA levels verified below 0.1%.
For catalog peptide APIs currently in stock, dispatch occurs within 24 to 48 hours of order confirmation, with transit time to Singapore typically requiring 2 to 4 business days. For custom synthesis campaigns or large multi-kilogram batches, production lead times range between 3 to 6 weeks, depending on sequence length and complexity.
Thinheal welcomes quality audits and technical due diligence from our institutional partners. We facilitate on-site audits at our Hangzhou R&D center and multi-ton synthesis base, as well as comprehensive remote digital audits, sharing facility layout, validation protocols, cleaning logs, and batch documentation under non-disclosure agreements (NDA).
Yes. Our peptide CDMO services cover custom peptide synthesis, route optimization, scale-up chemistry, and targeted synthesis of related substance impurity standards (such as deamidation products, deletion sequences, and enantiomers) required for validating regulatory analytical dossiers.
Whether you require exploratory gram-scale samples for Biopolis research or scalable, multi-kilogram commercial production for finished formulations, Thinheal delivers cost efficiency, chemical expertise, and rapid cold-chain transport to Singapore.